share_log

Veracyte Analyst Ratings

Veracyte Analyst Ratings

Veracyte 分析師評級
Benzinga ·  2023/10/23 21:06
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/23/2023 52.89% Goldman Sachs $37 → $32 Maintains Buy
10/20/2023 52.89% Goldman Sachs $37 → $32 Maintains Buy
10/10/2023 62.45% Stephens & Co. → $34 Reiterates Overweight → Overweight
08/09/2023 9.89% Morgan Stanley $22 → $23 Maintains Underweight
08/09/2023 67.22% Needham $34 → $35 Maintains Buy
05/08/2023 43.33% Stephens & Co. → $30 Reiterates → Overweight
02/23/2023 62.45% Needham $33 → $34 Maintains Buy
01/18/2023 — Raymond James Downgrades Outperform → Market Perform
01/05/2023 57.67% Scotiabank → $33 Initiates Coverage On → Sector Outperform
11/04/2022 5.11% Morgan Stanley $23 → $22 Maintains Underweight
11/04/2022 29% Raymond James $31 → $27 Maintains Outperform
11/03/2022 57.67% Needham $31 → $33 Maintains Buy
11/03/2022 67.22% SVB Leerink $30 → $35 Maintains Outperform
08/04/2022 48.11% Raymond James $30 → $31 Maintains Outperform
08/03/2022 48.11% Needham $26 → $31 Maintains Buy
05/05/2022 43.33% Stephens & Co. $44 → $30 Maintains Overweight
05/04/2022 9.89% Morgan Stanley $25 → $23 Maintains Underweight
05/04/2022 43.33% Raymond James $34 → $30 Maintains Outperform
05/04/2022 24.22% Needham $31 → $26 Maintains Buy
03/15/2022 48.11% Needham $35 → $31 Maintains Buy
03/02/2022 110.22% Stephens & Co. $52 → $44 Maintains Overweight
03/01/2022 62.45% Raymond James $62 → $34 Maintains Outperform
03/01/2022 91.11% SVB Leerink $45 → $40 Maintains Outperform
01/07/2022 148.45% Stephens & Co. → $52 Initiates Coverage On → Overweight
11/10/2021 196.23% Raymond James $50 → $62 Maintains Outperform
07/30/2021 100.67% Morgan Stanley $45 → $42 Maintains Underweight
07/30/2021 162.78% Needham $54 → $55 Maintains Buy
07/30/2021 186.67% SVB Leerink $55 → $60 Maintains Outperform
07/14/2021 162.78% SVB Leerink $65 → $55 Maintains Outperform
06/28/2021 138.89% Raymond James $45 → $50 Maintains Outperform
06/15/2021 115% Raymond James → $45 Initiates Coverage On → Outperform
05/18/2021 162.78% Truist Securities $84 → $55 Maintains Buy
05/12/2021 115% Morgan Stanley $65 → $45 Maintains Underweight
05/11/2021 210.56% SVB Leerink $75 → $65 Maintains Outperform
05/11/2021 158% Needham $88 → $54 Maintains Buy
02/22/2021 210.56% Morgan Stanley $35 → $65 Maintains Underweight
02/19/2021 210.56% Morgan Stanley $35 → $65 Maintains Underweight
02/18/2021 306.12% SVB Leerink $83 → $85 Maintains Outperform
02/08/2021 296.56% SVB Leerink $40 → $83 Maintains Outperform
01/28/2021 191.45% Truist Securities → $61 Initiates Coverage On → Buy
11/10/2020 — Keybanc Initiates Coverage On → Sector Weight
11/04/2020 100.67% BTIG $38 → $42 Maintains Buy
11/03/2020 91.11% Needham $37 → $40 Maintains Buy
11/03/2020 91.11% SVB Leerink $37 → $40 Maintains Outperform
09/09/2020 67.22% Morgan Stanley → $35 Initiates Coverage On → Underweight
07/31/2020 76.78% SVB Leerink $32 → $37 Maintains Outperform
07/31/2020 76.78% Needham $30 → $37 Maintains Buy
05/07/2020 52.89% SVB Leerink $29 → $32 Maintains Outperform
02/26/2020 43.33% Needham $34 → $30 Maintains Buy
07/31/2019 — Lake Street Initiates Coverage On → Buy
07/02/2019 57.67% Needham → $33 Initiates Coverage On → Buy
11/29/2018 — Janney Montgomery Scott Downgrades Buy → Neutral
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
10/23/2023 52.89% 高盛 $37→$32 維護 買
10/20/2023 52.89% 高盛 $37→$32 維護 買
2023年10月10日 62.45% 斯蒂芬斯公司 →$34 重申 超重→超重
08/09/2023 9.89% 摩根士丹利 $22→$23 維護 體重不足
08/09/2023 67.22% 李約瑟 $34→$35 維護 買
05/08/2023 43.33% 斯蒂芬斯公司 →$30 重申 →超重
02/23/2023 62.45% 李約瑟 $33→$34 維護 買
01/18/2023 - 雷蒙德·詹姆斯 評級下調 跑贏→市場表現
01/05/2023 57.67% 加拿大豐業銀行 →$33 開始承保 →板塊跑贏大盤
11/04/2022 5.11% 摩根士丹利 $23→$22 維護 體重不足
11/04/2022 29% 雷蒙德·詹姆斯 $31→$27 維護 跑贏大盤
11/03/2022 57.67% 李約瑟 $31→$33 維護 買
11/03/2022 67.22% SVB Leerink $30→$35 維護 跑贏大盤
08/04/2022 48.11% 雷蒙德·詹姆斯 $30→$31 維護 跑贏大盤
08/03/2022 48.11% 李約瑟 $26→$31 維護 買
05/05/2022 43.33% 斯蒂芬斯公司 $44→$30 維護 超重
05/04/2022 9.89% 摩根士丹利 $25→$23 維護 體重不足
05/04/2022 43.33% 雷蒙德·詹姆斯 $34→$30 維護 跑贏大盤
05/04/2022 24.22% 李約瑟 $31→$26 維護 買
03/15/2022 48.11% 李約瑟 $35→$31 維護 買
03/02/2022 110.22% 斯蒂芬斯公司 $52→$44 維護 超重
03/01/2022 62.45% 雷蒙德·詹姆斯 $62→$34 維護 跑贏大盤
03/01/2022 91.11% SVB Leerink $45→$40 維護 跑贏大盤
01/07/2022 148.45% 斯蒂芬斯公司 →$52 開始承保 →超重
2021年11月10日 196.23% 雷蒙德·詹姆斯 $50→$62 維護 跑贏大盤
07/30/2021 100.67% 摩根士丹利 $45→$42 維護 體重不足
07/30/2021 162.78% 李約瑟 $54→$55 維護 買
07/30/2021 186.67% SVB Leerink $55→$60 維護 跑贏大盤
07/14/2021 162.78% SVB Leerink $65→$55 維護 跑贏大盤
2021/06/28 138.89% 雷蒙德·詹姆斯 $45→$50 維護 跑贏大盤
2021/06/15 115% 雷蒙德·詹姆斯 →$45 開始承保 →跑贏大盤
2021/05/18 162.78% Truist證券 $84→$55 維護 買
2021/05/12 115% 摩根士丹利 $65→$45 維護 體重不足
2021/11/05 210.56% SVB Leerink $75→$65 維護 跑贏大盤
2021/11/05 158% 李約瑟 $88→$54 維護 買
02/22/2021 210.56% 摩根士丹利 $35→$65 維護 體重不足
02/19/2021 210.56% 摩根士丹利 $35→$65 維護 體重不足
02/18/2021 306.12% SVB Leerink $83→$85 維護 跑贏大盤
02/08/2021 296.56% SVB Leerink $40→$83 維護 跑贏大盤
2021年1月28日 191.45% Truist證券 →$61 開始承保 →購買
11/10/2020 - KeyBanc 開始承保 →行業權重
11/04/2020 100.67% BTIG $38→$42 維護 買
11/03/2020 91.11% 李約瑟 $37→$40 維護 買
11/03/2020 91.11% SVB Leerink $37→$40 維護 跑贏大盤
09/09/2020 67.22% 摩根士丹利 →$35 開始承保 →減持
07/31/2020 76.78% SVB Leerink $32→$37 維護 跑贏大盤
07/31/2020 76.78% 李約瑟 $30→$37 維護 買
05/07/2020 52.89% SVB Leerink $29→$32 維護 跑贏大盤
02/26/2020 43.33% 李約瑟 $34→$30 維護 買
2019年07月31日 - 萊克街 開始承保 →購買
2019年07月02日 57.67% 李約瑟 →$33 開始承保 →購買
2018年11月29日 - 詹尼·蒙哥馬利·斯科特 評級下調 購買→中性

What is the target price for Veracyte (VCYT)?

Veracyte的目標價是多少？

The latest price target for Veracyte (NASDAQ: VCYT) was reported by Goldman Sachs on October 23, 2023. The analyst firm set a price target for $32.00 expecting VCYT to rise to within 12 months (a possible 52.89% upside). 13 analyst firms have reported ratings in the last year.

高盛於2023年10月23日報道了Veracyte(納斯達克：VCYT)的最新目標價。這家分析公司將目標價定為32.00美元，預計VCyT將在12個月內上漲(可能上漲52.89%)。過去一年，有13家分析公司公佈了評級。

What is the most recent analyst rating for Veracyte (VCYT)?

Veracyte的最新分析師評級是什麼？

The latest analyst rating for Veracyte (NASDAQ: VCYT) was provided by Goldman Sachs, and Veracyte maintained their buy rating.

高盛對Veracyte(納斯達克代碼：VCYT)的最新分析師評級為買入，Veracyte維持買入評級。

When is the next analyst rating going to be posted or updated for Veracyte (VCYT)?

Veracyte的下一次分析師評級將於何時發佈或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veracyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veracyte was filed on October 23, 2023 so you should expect the next rating to be made available sometime around October 23, 2024.

分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Veracyte的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Veracyte的上一次評級是在2023年10月23日提交的，所以你應該預計下一次評級將在2024年10月23日左右的某個時候公佈。

Is the Analyst Rating Veracyte (VCYT) correct?

分析師評級Veracyte(VCyT)正確嗎？

While ratings are subjective and will change, the latest Veracyte (VCYT) rating was a maintained with a price target of $37.00 to $32.00. The current price Veracyte (VCYT) is trading at is $20.93, which is out of the analyst's predicted range.

雖然評級是主觀的，並將發生變化，但最新的Veracyte(VCyT)評級維持不變，目標價在37.00美元至32.00美元之間。Veracyte目前的交易價格為20.93美元，超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論